ASSOCIATION OF THE ANGIOTENSINOGEN GENE M235T POLYMORPHISM WITH ARTERIAL HYPERTENSION IN UZBEK PATIENTS WITH TYPE 2 DIABETES MELLITUS

Authors

  • Ellamonov Suxrobjon Numon ugli

Keywords:

type 2 diabetes mellitus, arterial hypertension, angiotensinogen, M235T polymorphism, genetic association, renin-angiotensin system.

Abstract

Background: The AGT M235T polymorphism (rs699) has been linked to plasma angiotensinogen levels and hypertension, but data from Central Asian type 2 diabetes mellitus (T2DM) cohorts remain scarce. Aim: To evaluate the association of AGT M235T genotypes with hypertension in Uzbek patients with T2DM. Methods: A case–control study included 132 patients with T2DM (70 hypertensive, 62 normotensive); genotyping was performed by PCR–RFLP. Results: The TT genotype was significantly more frequent in hypertensive patients (31.4% vs 14.5%, p<0.05); adjusted OR was 2.58 (95% CI 1.09–6.10). TT carriers showed higher systolic blood pressure (150.2±9.4 mmHg), a non-dipping nocturnal profile, and more frequent left ventricular hypertrophy and microalbuminuria, independent of glycemic control. Conclusion: The AGT 235T allele may be a genetic risk factor for hypertension in Uzbek T2DM patients and a potential marker for individualized RAAS-blockade therapy.

References

1.IDF Diabetes Atlas. 10th ed. Brussels: International Diabetes Federation; 2025.

2.Williams B., Mancia G., Spiering W. et al. ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2024.

3.Jeunemaitre X., Soubrier F., Kotelevtsev Y.V. et al. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992;71:169–180.

4.Inoue I., Nakajima T., Williams C.S. et al. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest. 1997;99:1786–1797.

5.Sethi A.A., Nordestgaard B.G., Gronholdt M.L., Tybjaerg-Hansen A. Angiotensinogen single nucleotide polymorphisms, elevated blood pressure, and risk of cardiovascular events. Hypertension. 2003;41:1202–1211.

6.Kato N., Sugiyama T., Morita H. et al. Angiotensinogen gene and essential hypertension in the Japanese: extensive association study. Circulation. 1999;100:1741–1745.

7.Giacchetti G., Sechi L.A., Griffin C.A. et al. The renin-angiotensin-aldosterone system, glucose metabolism and diabetes. Trends Endocrinol Metab. 2005;16:120–126.

8.Iwai N., Kajimoto K., Kokubo Y., Tomoike H. Extensive association analysis of AGT, ACE, and AGTR1 in a large Japanese population. J Hum Genet. 2006;51:389–396.

9.Radha V., Vimaleswaran K.S., Babu S. et al. Role of AGT polymorphisms in type 2 diabetes and diabetic nephropathy in an Asian Indian population. Mol Genet Metab. 2006;89:314–320.

10.Brenner B.M., Cooper M.E., de Zeeuw D. et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy (RENAAL). N Engl J Med. 2001;345:861–869.

11.O'zbekiston Respublikasi Sog'liqni saqlash vazirligi. Qandli diabetning diagnostikasi va davolash bo'yicha milliy protokol. Toshkent; 2024.

12.Ellamonov S.N. AGT M235T polimorfizmining 2 tip qandli diabet bilan og'rigan bemorlarda arterial gipertenziya rivojlanishidagi ahamiyati. Dissertatsiya materiallari. Samarqand; 2026.

Downloads

Published

2026-10-21

Conference Proceedings Volume

Section

Articles

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.